Resistance Transition of Pseudomonas aeruginosa in SARS-CoV-2-Uninfected Hospitalized Patients in the Pandemic
Open Access
- 1 October 2023
- journal article
- research article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 6717-6724
Abstract
Objective: To investigate the impact of coronavirus disease 2019 (COVID-19) specified preventive and control measures on the distribution and resistance transition of Pseudomonas aeruginosa (P. aeruginosa) in uninfected hospitalized patients during the pandemic. Methods: This retrospective study retrieved data from 316 P. aeruginosa isolates in the year pre-COVID-19 (n=131) pandemic and the year under COVID-19 specified preventive and control (post-pandemic year, n=185), compared the general characteristics, laboratory results, and antimicrobial susceptibility tests of P. aeruginosa between the two groups. Results: Compared with the pre-pandemic year, the isolation rate of P. aeruginosa (14.35% vs 22.31%, P< 0.001) increased, while the rate of drug resistant P. aeruginosa decreased significantly (29.77% vs 19.45%, P< 0.001) in the post-pandemic year; Prescription of β-Lactams (30.5% vs 50.0%, P< 0.01) also increased significantly. The resistance rates of P. aeruginosa isolates to ceftazidime (P< 0.01), ciprofloxacin (P< 0.01), and gentamicin (P< 0.001) increased, whereas the resistance rates to piperacillin/tazobactam (P< 0.01) and imipenem (P< 0.05) decreased significantly. Conclusion: The COVID-19 specified preventive and control measures have influenced the distribution and resistance transition of P. aeruginosa, further verifications are needed in future research.Keywords
This publication has 16 references indexed in Scilit:
- Increased antimicrobial resistance during the COVID-19 pandemicInternational Journal of Antimicrobial Agents, 2021
- Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic ColonizerFrontiers in Cellular and Infection Microbiology, 2021
- Impact of the COVID-19 Pandemic on Antibiotic Prescribing for Common Infections in The Netherlands: A Primary Care-Based Observational Cohort StudyAntibiotics, 2021
- The COVID-19 pandemic: a global health crisisPhysiological Genomics, 2020
- Tackling antimicrobial resistance in the COVID-19 pandemicBulletin of the World Health Organization, 2020
- Antimicrobial use, drug-resistant infections and COVID-19Nature Reviews Microbiology, 2020
- Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolutionDrug Resistance Updates, 2019
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisThe Lancet Infectious Diseases, 2018
- Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspectiveClinical and Experimental Optometry, 2017
- Susceptible, Intermediate, and Resistant – The Intensity of Antibiotic ActionDeutsches Ärzteblatt international, 2008